Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Adjuvant combinations comprising alpha-galactosylceramide or iGb3, CD40 agonists and antigen

Adjuvant combinations comprising alpha-galactosylceramide or iGb3, CD40 agonists and antigen

US Patent 10463731 · Granted Nov 5, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for treating cancer2025
Antigen binding polypeptides2025
Compositions for treating cancer2025
Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
Antigen binding polypeptides2025
VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergi2024
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders2024
Vista antagonist and methods of use2024
Autoimmune disorder treatment using RXR agonists2023
Vista antagonist and methods of use2023
Nucleic acids encoding an anti-CD154 antibody comprising E269R and K322A mutatio2023
Autoimmune disorder treatment using RXR agonists2023